BTNL2 and colorectal cancer: Thus, it is becoming evident that BTNL2 possesses an immunoregulatory role, which is likely critical in the progression of some malignancies, including colorectal cancer, where it has been demonstrated that BTNL-2 ablation in these mice reduced tumorigenesis by downregulating IL-22 production [29] (Table 2).